Clincosm LogoSign in Get a demo

Metastatic Cancer

Showing 51 - 75 of 551
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, CHF, COPD Trial in United States (Respecting Choices First Steps, Five Wishes Form)

Enrolling by invitation
  • Metastatic Cancer
  • +8 more
  • Respecting Choices First Steps
  • Five Wishes Form
  • Birmingham, Alabama
  • +3 more
Jan 4, 2023

Lung Tumor, Metastatic Cancer Trial in Orange (Irreversible electroporation (IRE) ablation, Radiation Therapy)

Recruiting
  • Lung Tumor
  • Metastatic Cancer
  • Irreversible electroporation (IRE) ablation
  • Radiation Therapy
  • Orange, California
    Chao Family Comprehensive Cancer Center University of California
Jan 4, 2023

KRAS Activating Mutation, Metastatic Cancer, Pancreas Cancer Trial in Saint Louis (avutometinib (VS-6766) and defactinib in

Recruiting
  • KRAS Activating Mutation
  • +4 more
  • avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab

Not yet recruiting
  • HCC - Hepatocellular Carcinoma
  • +2 more
  • Ipilimumab Injection
  • +2 more
  • Créteil, France
  • +7 more
Dec 27, 2022

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01876, Nivolumab, Ipilimumab)

Completed
Has Results
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +37 more
Dec 6, 2022

Cancer, Tumor, Solid, Nonsmall Cell Lung Cancer Trial in United States (HMBD-002, Pembrolizumab)

Recruiting
  • Cancer
  • +6 more
  • Duarte, California
  • +6 more
Dec 26, 2022

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Metastatic Cancer, Urothelial Carcinoma Trial (avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin)

Not yet recruiting
  • Metastatic Cancer
  • Urothelial Carcinoma
  • avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
  • (no location specified)
Dec 19, 2022

Recurrent Cancer, Metastatic Cancer, Advanced Malignancies Trial (INCAGN01876, retifanlimab)

Recruiting
  • Recurrent Cancer
  • +3 more
  • INCAGN01876
  • retifanlimab
  • Birmingham, Alabama
  • +17 more
Dec 13, 2022

Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer Trial in Worldwide (radiation, procedure, drug)

Active, not recruiting
  • Prostate Cancer
  • +3 more
  • whole pelvic radiotherapy
  • +3 more
  • Melbourne, Australia
  • +28 more
Dec 12, 2022

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (TJ210001)

Completed
  • Solid Tumor
  • +2 more
  • Aurora, Colorado
  • +3 more
Dec 9, 2022

Solid Tumor, Metastatic Cancer Trial in United States (RP-3500, External Beam Radiotherapy (EBRT))

Recruiting
  • Solid Tumor
  • Metastatic Cancer
  • RP-3500
  • External Beam Radiotherapy (EBRT)
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer, Prostate Cancer Trial in Saint Louis, Madison (pTVG-HP, pTVG-AR,

Recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • pTVG-HP
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 21, 2022

Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

Recruiting
  • Metastatic Cancer
  • +5 more
  • Stereotactic Body Radiotherapy
  • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
  • Hartford, Connecticut
  • +9 more
Nov 17, 2022

Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.

Recruiting
  • Pelvic Cancer
  • +8 more
  • Ultrasound guided tru-cut biopsy
  • Leuven, Belgium
  • +3 more
Nov 3, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Prostate Cancer, Radiotherapy Side Effect, Metastatic Cancer Trial in Umeå (Moderate hypo-fractionation,

Recruiting
  • Prostate Cancer
  • +2 more
  • Moderate hypo-fractionation
  • Ultra-hypo-fractionation
  • Umeå, Sweden
    Cancercenter University hospital of Umeå
Nov 1, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Metastatic Cancer, Renal Cancer Trial in Indianapolis, Columbus, Philadelphia (Atezolizumab, Bevacizumab, Entinostat)

Suspended
  • Metastatic Cancer
  • Renal Cancer
  • Indianapolis, Indiana
  • +3 more
Oct 29, 2022

Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)

Completed
Has Results
  • Lung Cancer
  • Metastatic Cancer
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Oct 29, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

Active, not recruiting
  • Breast Cancer
  • +11 more
  • radionuclide imaging
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Oct 20, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Cholesterol metabolism disruption
  • Quebec city, Quebec, Canada
    CHU de Québec-Université Laval
Oct 17, 2022